About

The high prevalence and increasing incidence of obesity and associated cardiovascular risk emphasises the need to focus on obesity reduction in this high-risk population.

Metabolic syndrome (MetS) is the coexistence of obesity-related cardiovascular risk factors including hypertension, diabetes and dyslipidaemia. MetS is a precursor for atherosclerosis, including premature coronary artery disease, and cardiovascular mortality.

Related Articles

Articles

Impacts of Adipocytokines and Obesity-associated Inflammatory Markers on…

Morihiro Matsuda,

Citation: European Cardiology Review 2020;15:e45.

New Perspectives on Atherogenic Dyslipidaemia and Cardiovascular Disease

Alberto Lorenzatti, Peter P Toth,

Published:

Citation: European Cardiology Review 2020;15:e04.

Sodium–Glucose Cotransporter-2 Inhibitors and Heart Failure Prevention in…

Muhammad Shahzeb Khan, Javed Butler,

Citation: Cardiac Failure Review 2019;5(3):169–72.

Relationship Between Obstructive Sleep Apnoea and AF

Ghanshyam Shantha, Frank Pelosi, Fred Morady,

Citation: Arrhythmia & Electrophysiology Review 2019;8(3):180–3.